Inclusion Criteria:  Chronic leg ulcers and chronic diabetic foot ulcers in need of debridement Male or female, 18 years of age and above Able to read and understand the Patient Informed Consent and to provide meaningful written informed consent  Exclusion Criteria:  Known allergy/hypersensitivity to any of the components of ChloraSolv Renal insufficiency defined as serum creatinine >200 μmol/L Macroangiopathy expected to demand vascular intervention or percutaneous angioplasty performed less than 3 months after start of treatment; toe pressure <30mm Hg Kidney or pancreas transplanted Patient under cortisone treatment >60mg/day Patient treated with chemotherapy or any other immune-inhibiting drugs 12 months before start of treatment Other identified on-going pathologies in the area of wound, such as cancer Pregnancy or breastfeeding Subjects included in other ongoing clinical investigations which could interfere with this investigation, as judged by the investigator Subjects not suitable for the investigation according to the investigator's judgment or other significant medical conditions that the investigator determines could interfere with compliance or investigation assessments.